Mortality and morbidity among individuals with hypertension receiving a diuretic, ace inhibitor, or calcium channel blocker
JAMA Network Open
2023-12-04
(Press-News.org)
About The Study: In this prespecified secondary analysis of outcomes of 32,000 participants in a randomized clinical trial and post-trial up to 23 years later among adults with hypertension and coronary heart disease risk factors, cardiovascular disease mortality was similar between all three antihypertensive treatment groups (thiazide-type diuretic, calcium channel blocker, or angiotensin-converting enzyme [ACE] inhibitor). ACE inhibitors increased the risk of stroke outcomes by 11% compared with diuretics, and this effect persisted well beyond the trial period.
Authors: Jose-Miguel Yamal, Ph.D., of the University of Texas Health Science Center at Houston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.44998)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.44998?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120423
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-12-04
About The Study: The results of this study that included nearly 16,000 kindergarten children indicated that both total screen time and different types of content were associated with mental health problems in children ages 3 to 6. Limiting children’s screen time, prioritizing educational programs, and avoiding non–child-directed programs are recommended.
Authors: Fan Jiang, M.D., Ph.D., and Yunting Zhang, Ph.D., of Shanghai Jiao Tong University in Shanghai, China, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this ...
2023-12-04
About The Study: Maternal depressive symptoms were associated with slower fetal growth rate in the critical rapid growth stage before delivery in this study including 2,676 mother-offspring dyads. Early screening for depressive disorders in pregnant women appears to be essential for fetal growth and later health.
Authors: Zhenmi Liu, Ph.D., and Jiaqiang Liao, Ph.D., of Sichuan University in Chengdu, China, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.46018)
Editor’s Note: Please see ...
2023-12-04
About 20 % of patients whose medical records showed them as being alive with a serious illness were in fact deceased according to California data, leading to hundreds of unnecessary interactions such as appointment reminders, prescription refills and other kinds of wasteful outreach that strain resources and healthcare workers’ time.
The data gap is due to California law that makes these full death data available only “for purposes of law enforcement or preventing fraud,” according to a UCLA-lead research team. Even a real-time death database maintained by the National Association for Public Health ...
2023-12-04
Francis Crick Institute press release
Under strict embargo: 16:00hrs GMT Monday 4 December 2023
Peer reviewed
Experimental study
Animals
Researchers at the Francis Crick Institute have discovered that a common dietary supplement could protect against chronic Cryptosporidium infections which are particularly prevalent in children under two and in areas with poorer sanitation.
Cryptosporidium is a parasite that infects and damages the small intestine. It is one of the leading causes of diarrhoea-related deaths ...
2023-12-04
Ketamine – an anesthetic also known for its illicit use as a recreational drug – has undergone a thorough reputational rehabilitation in recent years as the medical establishment has begun to recognize its wide-ranging therapeutic effects. The drug is increasingly used for a range of medical purposes, including as a painkiller alternative to opioids, and as a therapy for treatment-resistant depression.
In a new study published in the journal Cell Reports, Columbia biologists and biomedical engineers mapped ketamine’s effects on the brains of mice, and found that repeated use over extended periods of time leads to widespread structural changes in the brain’s ...
2023-12-04
Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow — advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.
Hormone therapy, also known as antiandrogen therapy, plays a crucial role in temporarily halting the growth of prostate cancer cells. Over time, however, the majority of patients eventually see their cancer return and progress, underscoring the pressing need for continued advancements to enhance clinical ...
2023-12-04
Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge.
An international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia) and other institutions has discovered a potential way to target the androgen receptor, the most prominent oncogenic transcription factor in prostate cancer, based on its propensity to form droplets also known as condensates.
The results described ...
2023-12-04
Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, has been honored with the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH) for her groundbreaking research to develop and advance innovative cell therapies for cancer using natural killer (NK) cells.
“I am fortunate to be able to engage in research that I am passionate about, to mentor incredible young scientists, and to collaborate with a remarkable team of researchers and clinicians. But most importantly, I am blessed to have the opportunity to undertake research that has the potential to ...
2023-12-04
A study supported by the National Institutes of Health suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure. This finding, published in Nature Neuroscience, may shed light on new ways to counteract the effects of high blood pressure on cognition. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), a part of NIH.
“The role of immune signaling in cognitive decline is critically important to understand,” said Roderick Corriveau, Ph.D., program director, NINDS. “These findings offer insight ...
2023-12-04
In a recent study led by University of Florida astronomer Adam Ginsburg, groundbreaking findings shed light on a mysterious dark region at the center of the Milky Way. The turbulent gas cloud, playfully nicknamed “The Brick” due to its opacity, has sparked lively debates within the scientific community for years.
To decipher its secrets, Ginsburg and his research team, including UF graduate students Desmond Jeff, Savannah Gramze, and Alyssa Bulatek, turned to the James Webb Space Telescope (JWST). The implications of their observations, published in ...
LAST 30 PRESS RELEASES:
[Press-News.org] Mortality and morbidity among individuals with hypertension receiving a diuretic, ace inhibitor, or calcium channel blocker
JAMA Network Open
